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Abstract
Background: Tumor suppressor WOX1 (also named WWOX or FOR) is known to participate in neuronal apoptosis in vivo.
Here, we investigated the functional role of WOX1 and transcription factors in the delayed loss of axotomized neurons in
dorsal root ganglia (DRG) in rats.
Methodology/Principal Findings: Sciatic nerve transection in rats rapidly induced JNK1 activation and upregulation of
mRNA and protein expression of WOX1 in the injured DRG neurons in 30 min. Accumulation of p-WOX1, p-JNK1, p-CREB, p-
c-Jun, NF-kB and ATF3 in the nuclei of injured neurons took place within hours or the first week of injury. At the second
month, dramatic nuclear accumulation of WOX1 with CREB (.65% neurons) and NF-kB (40–65%) occurred essentially in
small DRG neurons, followed by apoptosis at later months. WOX1 physically interacted with CREB most strongly in the
nuclei as determined by FRET analysis. Immunoelectron microscopy revealed the complex formation of p-WOX1 with p-
CREB and p-c-Jun in vivo. WOX1 blocked the prosurvival CREB-, CRE-, and AP-1-mediated promoter activation in vitro.I n
contrast, WOX1 enhanced promoter activation governed by c-Jun, Elk-1 and NF-kB. WOX1 directly activated NF-kB-
regulated promoter via its WW domains. Smad4 and p53 were not involved in the delayed loss of small DRG neurons.
Conclusions/Significance:RapidactivationofJNK1andWOX1duringtheacutephaseofinjuryiscriticalindeterminingneuronal
survivalor death, as both proteins functionally antagonize. In the chronic phase, concurrent activation of WOX1, CREB, and NF-kB
occurs in small neurons just prior to apoptosis. Likely in vivo interactions are: 1) WOX1 inhibits the neuroprotective CREB, which
leads to eventual neuronal death, and 2) WOX1 enhances NF-kB promoter activation (which turns to be proapoptotic). Evidently,
WOX1 is the potential target for drug intervention in mitigating symptoms associated with neuronal injury.
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Introduction
Tumor suppressor WW domain-containing oxidoreductase, liter-
ally known as human WWOX or FOR and murine WOX1, has been
shown to participate in neurodegeneration in vivo [1–3]. The human
or mouse WWOX/Wwox gene encodes a full-length 46-kDa protein
and isoforms [1,4–9], and alteration of this gene is associated with
development of many types of cancers [10,11; reviews]. When
overexpressed, WWOX/WOX1 induces apoptosis in vitro and
suppresses tumor growth in vivo [10,12]. The wild type protein
possesses two N-terminal WW domains, a nuclear localization
sequence between these domains, and a C-terminal short-chain
alcohol dehydrogenase/reductase (SDR) domain. Under stress
conditions, WOX1 may undergo Tyr33 phosphorylation in the first
WW domain and then relocates to the mitochondria and nuclei for
inducing apoptosis both in vivo and in vitro [2,3,6,13,14].
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7820The molecular mechanism whereby WOX1 participates in
neuronal death is largely unknown and remains to be established
[1–3]. Expression of WOX1 and isoform WOX2 is significantly
decreased in the hippocampal neurons of patients with Alzhei-
mer’s disease [1]. This downregulation negatively correlates with
an increased expression of hyperphosphorylated Tau and
formation of neurofibrillary tangles. Suppression of WOX1
expression by small interfering RNA spontaneously induces Tau
phosphorylation in neuroblastoma cells [1], suggesting a role of
WOX1 in controlling Tau tangle formation. Light-induced retinal
damage in rats involves WOX1 phosphorylation at Tyr33 and
subsequent translocation to the mitochondria and nuclei [2]. In a
Parkinsonism model, MPP
+ (1-methyl-4-phenylpyridinium) was
shown to stimulate an initial increase in the complex formation of
WOX1 and JNK1, followed by dissociation, in the cortical and
striatal neurons in rats, suggesting that the dissociation is needed
for WOX1 to exert neuronal death [3]. JNK1 is known to
antagonize the apoptotic function of WOX1 [13,15].
WOX1expression isupregulated intheearlystagesofdeveloping
central and peripheral nervous systems in mouse embryos [16].
Also, WOX1 is present in neural crest-derived structures such as
cranial and spinal ganglia (or dorsal root ganglia, DRG) during fetal
and postnatal development [16]. Whether WOX1 plays a critical
role in neural development remains to be established.
Primary sensory neurons in the DRG convey information along
theiraxonsfromperipherytothe centralnervesystem(CNS).When
injurytoanadultperipheralnerve occurs,mRNAand proteinlevels
are rapidly altered in the injured sensory neurons. Transcription
factor c-Jun is strongly activated in response to ischemia, UV
radiation and oxidizing compounds [17,18; reviews]. Also, c-Jun
protein and mRNA levels are increased following blocking axonal
transport by peripheral nerve axotomy or spinal cord hemisection
[19–21]. c-Jun is essential for axonal regeneration [22–24] and may
contribute to neuropathic pain [25]. Transcription factor CREB is
also significantly increased during spinal cord injury [26].
Differential expression of these transcription factors in a prolonged
manner occurs during the course of sciatic nerve injury [26]. How
these transcription factors functionally interact to ultimately
generate neurodegeneration is largely unknown.
Here, we established a comprehensive time-course profile of
transcription factors that were differentially expressed in both large-
medium and small neurons following axotomy for 2 months in rats.
We also demonstrated axotomy-induced activation of WOX1 (p-
WOX1), via Tyr33 phosphorylation and nuclear accumulation, in
the axotomized DRG neurons in rats. Finally, we examined binding
and functional regulation of transcription factors by WOX1 in
cultured cells. Our data suggest a balanced control of transcription
factors by WOX1 is associated with prolonged survival (or delay
apoptosis) in axotomized neurons in vivo.
Results
Rapid Upregulation of Wwox Gene Expression in DRG
Neurons upon Sciatic Nerve Transection
By in situ hybridization, we showed that there was a rapid
increase in the expression of Wwox mRNA in the ipsilateral,
injured L4/5 DRG neurons in rats post axotomy for 30 min. The
mRNA levels were then reduced in 6 hr, followed by gradual
increase reaching a maximal expression at month 2 (Fig. 1A and
1B). In the contralateral, uninjured side of DRG neurons, Wwox
gene expression was relatively low initially, but was then increased
gradually to a maximal extent by the end of month 2 (Fig. 1A and
1B). Statistical differences regarding the gene expression between
ipsilateral and contralateral sides with time are shown (Fig. 1B). In
negative controls, sense-probe for Wwox mRNA produced no
signals for the DRG sections (Fig. 1A). In the sham control, the
Wwox mRNA was barely detectable (Fig. 1A and 1B).
To verify the results from in situ hybridization, we performed
quantitative polymerase chain reaction (qPCR) and determined
that there was a rapid, significant increase in the mRNA levels of
Wwox in 30 min post axotomy in the injured neurons, as
compared to the experiments at time 0 (Fig. 1C). The expression
was then reduced within 8 hr (data not shown).
Morphological and metabolic changes were observed in the
neuronal bodies upon peripheral axotomy, as revealed by Nissl
staining. Chromatolysis was observed in some of the transected DRG
neurons within 6 hr, whereas no morphological changes were found in
the non-operated side (see Fig. S1 in the Supporting Information).
Presence of large vacuoles in the cytoplasm and eccentric nuclei was
observed 3–7 days post injury (Supporting Fig. S1). Approximately less
than 5% neuronal death was observed post axotomy for 2 months, as
shown by morphological features and TUNEL stain (Supporting Fig.
S1). Cell death was increased with time. Tandrup et al. demonstrated
that axotomy-induced neuronal death in DRG started to occur by
week 8, and continued to increase up to 37% death by week 32 [27].
Axotomy Induces Protein Expression and Activation of
WOX1 in DRG Neurons
We investigated axotomy-induced protein expression and
activation of WOX1 in damaged DRG neurons, by immunohis-
tochemistry and Western blotting using specific antibodies against
WOX1 (against the first WW domain, or a region between 1
st and
2
nd WW domain) [6,16] and Tyr33 phosphorylation [13].
Tyr33-phosphorylation in WOX1 occurred in the injured DRG
neurons 30 min to 6 hr post axotomy, and the phosphorylation
continued to increase gradually in 2 months (Fig. 2A). Accumu-
lation of p-WOX1 in the nuclei of axotomized neurons occurred
in a time-related manner (Fig. 2A). The ipsilateral injured sites
have significantly greater numbers of neurons with nuclear p-
WOX1 than those in the contralateral sites (Fig. 2B).
Similarly, we determined the total levels of WOX1 protein by
specific antibodies against the first WW domain. WOX1 was
distributed ubiquitously in the cytoplasm of unstimulated DRG
neurons or post surgery at time 0, and the distribution was not
altered significantly within 1 hr after axotomy. 3 to 6 hr later, the
number and staining intensity of WOX1-expressing neurons,
along with protein accumulation in the nuclei, were increased
(Supporting Fig. S2). Upregulation of WOX1 expression contin-
ued to occur in the injured DRG 3 to 7 days later.
Notably, post sciatic nerve transection for 2 months, p-WOX1
was mainly accumulated in the nuclei of small neurons (,20 mm
in diameter), rather than in medium (20–30 mm)-to-large
(.30 mm) sensory neurons in both contralateral and ipsilateral
sides (Supporting Fig. S3; see Fig. 2 for comparison). Similarly, at
month 2, there was a dramatic increase in the accumulation of
total WOX1 protein (phosphorylated and non-phosphorylated) in
the nuclei of small neurons in the contralateral non-operated sides
(Supporting Fig. S2). The average sizes of p-WOX1-expressing
neurons were significantly larger in the operated sides than in the
non-operated sides (ipsilateral neurons: 28.861.8 mm in diameter;
contralateral neurons: 20.461.7 mm; p,0.05).
No Differences in WOX1 Activation in Ipsilateral and
Contralateral Sides of Spinal Cord from Sciatic Nerve
Transection
In the spinal cord, Wwox mRNA and protein were moderately
expressed in motoneurons (Supporting Figs. S4 and S5). After
WWOX/WOX1 in Axotomy
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the motoneurons of dorsal horns were similar between the
damaged and control sides (Supporting Fig. S4). Accumulation
of WOX1 protein in the nuclei of motoneurons of dorsal horns in
both ipsilateral and contralateral sides was observed 1 to 3 days
post surgery (Supporting Fig. S4). Also, a similar extent of p-
WOX1 accumulation in the nuclei was observed in the injured
and non-injured sides of ventral horns (Supporting Fig. S5). No p-
WOX1 accumulation in the nuclei of normal motoneurons was
shown (Supporting Fig. S5).
To confirm the observations from tissue staining by immunohis-
tochemistry, DRG samples were isolated from the control and
axotomized rats. Cytosolic and nuclear fractions were prepared from
DRGs. Accumulation of WOX1 in the nuclei in the injured DRG
occurred 6 hr post axotomy, as determined by Western blotting
(Supporting Fig. S6). In contrast, there were no differences in the
protein levels of WOX1 between contralateral and ipsilateral sides,
either in ventral or dorsal horn, of the spinal cord (Supporting Fig. S7).
Axotomy-Induced WOX1 Activation Is Independent of
p53
WOX1 may physically interact with p53 and JNK1 to regulate
apoptosis in vitro and in vivo [6–8,13,15,16]. By using p53 knockout
mice, axotomy induced accumulation of p-WOX1, c-Jun, p-JNK1
and ATF3 in the nuclei of ipsilateral DRG neurons post injury for
1 day (data not shown). In the contralateral DRG neurons, p-
WOX1, c-Jun and JNK1 were also observed in the nuclei, whereas
ATF3 was mainly present in the cytoplasm. The observations
suggest that nuclear relocation of WOX1, JNK1 and transcription
factors is a p53-independent event.
Dramatic Co-Activation of WOX1 with Transcription
Factor CREB and NF-kB in Small Neurons at Month 2
Post-Injury Correlates with Initiation of Neuronal Death
In time course analyses, we examined a panel of transcription
factors [18,28,29], and established the kinetics of nuclear
accumulation of p-WOX1, c-Jun, ATF3, JNK, NF-kB, and p-
CREB in response to axotomy (Figs. 3 and 4). At month 2, sciatic
nerve transection induced a time-dependent accumulation of p-
CREB mainly in the nuclei of small neurons, rather than in the
medium-large neurons (Fig. 3). When small neurons started
undergoing apoptosis at month 2 (Supporting Fig. S1), dramatic
co-activation of WOX1 (.65% of cells), CREB (.65%) and NF-
kB (40–65%) occurred in the small neurons of both non-injured
and injured sides (Fig. 4). Nuclear accumulation of c-Jun and JNK
was less than 40% in the small neurons at month 2.
High levels of nuclear ATF3 (.65%) were observed approx-
imately 6–24 hours post axotomy and sustained up to 2 months in
injured DRG neurons, whereas no apparent expression of ATF3
was shown in non-operated side (Fig. 4). ATF3 belongs to the
CREB/ATF protein family.
Expression and activation of Smad4 of the TGF-b pathway
were barely detectable in both injured and non-injured neurons
(,5% of cells) (Fig. 4), whereas Smad4 is mainly present in the
glial cells (Supporting Fig. S8). The levels of Smad4 were greatly
increased in the glial cells post axotomy for 2 months. WOX1 has
Figure 1. Wwox gene expression post peripheral nerve injury in rats. (A) As determined by in situ hybridization, there was a rapid
upregulation of rat Wwox mRNA in 30 min in the ipsilateral DRG neurons upon axotomy, followed by reduction in 6 hr and then gradual increase
from day 1 to month 2. In the contralateral uninjured DRG, the maximal increase in Wwox mRNA is at month 2. Little or no signal was observed for the
non-axotomized sham control (top right). No signal for sense-probe reaction was observed (bottom right). White scale bar=20 mm (see the bars at
day 60th). (B) 30–50 cells were randomly selected from each section (3–5 sections used), and the intensity of each individual cell was quantified by
ImagePro. Statistical analysis by one-way ANOVA is shown. Contra, contralateral. Ipsi, ipsilateral. (C) Post axotomy for 30 min, there was a significant
increase in the expression of Wwox mRNA (picogram per 1 microgram total RNA), as determined by qPCR. The data were normalized to the mRNA
levels of GPDH (glycerol-3-phosphate-dehydrogenase) (n=3, p,0.01; Student’s t test).
doi:10.1371/journal.pone.0007820.g001
WWOX/WOX1 in Axotomy
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inducing cancer cell death [30].
WOX1 Blocks Promoter Activation Driven by CREB but
Enhances the Activation by NF-kB
We determined whether activated WOX1 in the nuclei may
control the function of transcription factors in vivo, thereby
affecting neuronal degeneration or regeneration. By in vitro
promoter assay using luciferase [31,32] and GFP as reporters,
we determined that transiently overexpressed WOX1 enhanced
the promoter activity driven by c-Jun and Elk-1 (Fig. 5A–C) and
NF-kB (Fig. 5E,F), respectively. Cumulative evidence shows that c-
Jun is involved in the neuronal apoptosis [25,33], although it may
be needed for efficient axonal regeneration [23]. Elk-1 is involved
in cell proliferation [34,35]. Constitutive expression of Elk-1
induces apoptosis in certain types of cells [36,37].
In contrast, transiently overexpressed WOX1 significantly
blocked the activity of promoter elements responsive to transcrip-
tion factors CREB, CRE, and AP-1 (Fig. 5D). These transcription
factors are generally considered as prosurvival for transcribing
proteins to support cell growth [18,38,39].
In the GFP reporter assay, we showed that WOX1 significantly
enhanced NF-kB-induced promoter activation by approximately
4.69 fold, compared to vector alone (p,0.00001; Fig. 5E, F). Next,
we determined which domain in WOX1 is responsible for
enhancing promoter activation. Our data showed that the N-
terminal first and second WW domains of WOX1 dramatically
enhanced the activation of promoter by 7.90 fold, whereas the C-
terminal SDR domain had no effect (Fig. 5E, F).
The WW Domain Area of WOX1 Binds CREB and the
Binding Occurs Most Strongly in the Nucleus
By Fo ¨rster/Fluorescence resonance energy transfer (FRET), we
determined whether WOX1 regulates the function of transcription
factors via direct binding interactions. Primary DRG neurons were
grown overnight on cover slides and transfected with WOX1-
DsRed and CREB-EGFP using liposome-based GeneFECTOR,
followed by culturing for 24–48 hr. The cells were treated with
deferoxamine (DFO; 500 mM) to generate hypoxic conditions to
induce apoptotic stress for 2 hours. FRET analysis showed that
EGFP and DsRed together did not generate binding interactions,
as revealed by a low level of binding energy (see color scale;
Fig. 6A). When both WOX1 and CREB were colocalized in the
nuclei, their binding was significantly greater than in the
cytoplasm (Fig. 6B, E). Similarly, the strength of binding of the
WW domain area of WOX1 with CREB was significantly
increased in the nuclei than in the cytoplasm (Fig. 6C, E).
Exposure of neurons to DFO for 2 hours resulted in increased
binding of WOX1 with CREB in both cytoplasm and nuclei
(Fig. 6D, E). In parallel experiments, we carried out FRET
analyses using ECFP-WOX1 and EYFP-CREB, or ECFP-CREB
and EYFP-WOX1, and similar results were observed (data not
shown).
To further analyze the role of WOX1 in the nucleus, we
determined colocalization of WOX1 with transcription factors by
dual-antibody immunostaining and confocal microscopy. Activat-
ed WOX1 colocalized with CREB, p-c-Jun, p-JNK1 and ATF3 in
the nuclei of injured DRG neurons as determined at both early
acute and late chronic stages post injury (data not shown). Low
Figure 2. Axotomy induces accumulation of Tyr33-phosphorylated WOX1 (p-WOX1) in the nuclei of DRG neurons. (A) Gradual
increase in the accumulation of p-WOX1 in the nuclei of DRG neurons, both ipsilateral and contralateral, is shown at each indicated time. See the
signal in brown color. Scale bar=20 mm. (B) Statistical analysis revealed that the injured DRG neurons at the ipsilateral sides possessed significantly
greater numbers of nuclear p-WOX1 than those in the contralateral sides (,450 neurons counted in 3 separate sections). Statistical analysis by one-
way ANOVA is shown. Contra, contralateral. Ipsi, ipsilateral.
doi:10.1371/journal.pone.0007820.g002
WWOX/WOX1 in Axotomy
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were also co-expressed in the nuclei in the injured DRG neurons
(data not shown). Additionally, we carried out co-immunoprecip-
itation, and showed the binding of endogenous WOX1 with c-Jun
or p-CREB in cultured neuroblastoma SK-N-SH cells (data not
shown).
Complex Formation of p-WOX1 with c-Jun and p-CREB
Determined by Immunoelectron Microscopy (Immuno-
EM)
We further verified the in vivo interactions in tissue sections by
immuno-EM. Upregulation of the complex formation of p-WOX1
and p-CREB in the DRG neurons ipsilaterally to axotomy was
shown (small immunogold particles for p-WOX1, and large
particles for p-CREB; Fig. 7). The nuclear accumulation of p-
CREB reached maximally 24 hours after axotomy, followed by
disappearance.
Colocalization of p-WOX1 with p-c-Jun was shown mainly in
the nuclei 6 hours after axotomy, whereas no apparent binding of
p-WOX1 with c-Jun was found (large particles for p-c-Jun; small
particles for p-WOX1; Supporting Fig. S9a-c). Interestingly, the
protein levels (or the numbers of high-density particles) were
higher in the medium-to-large neurons than in the small neurons
(Supporting Fig. S9a–c). 3 days later, complex formation of p-
WOX1 and p-c-Jun was shown in many small neurons
(Supporting Fig. S9d). These ultrastructural data are similar to
those observed by immunohistochemistry. In addition, numerous
particles of protein complexes were present within and around the
small and large lysosome-like vesicles (Supporting Fig. S9e,f),
suggesting that these protein complexes are shuttling between the
cytoplasm and nucleus.
Functional Inactivation of CREB Augments WOX1-
Mediated Apoptosis of Neuroblastoma Cells
Finally, we examined whether WOX1-mediated inhibition of
CREB transcriptional function augments its apoptotic function.
SK-N-SH neuroblastoma cells were transfected with the expres-
sion constructs of WOX1 and CREB by electroporation. The cells
were cultured for 48 hr, followed by processing cell cycle analysis
by flow cytometry. CREB alone did not induce cell death, but
enhanced WOX1-mediated apoptosis of SK-N-SH cells, as
evidenced by an increased cell population at the SubG1 phase
and a reduced population at the G1 phase (Fig. 8A). Dominant
negative WOX1 (dn-WOX1) blocks WOX1 phosphorylation at
Tyr33 and the apoptotic function of WOX1 and p53 [1–3,10,12–
15]. Transient overexpression of dn-WOX1 did not cause cell
death, and there was no increases in apoptosis by the presence of
CREB (Fig. 8B). Staurosporine treatment is considered as a
positive control of apoptosis (Fig. 8A,B).
Discussion
In this study, we have demonstrated the kinetics of phosphor-
ylation and nuclear accumulation of JNK1, WOX1 and
transcription factors during the acute and chronic phases of
sciatic nerve transection in rats and in p53 knockout mice. In
brief, time-dependent WOX1 activation is accompanied by
certain other transcription factor, and the activity of which could
be modulated by WOX1. A balanced interaction is critical in
deciding cell fate. For the delayed loss in small neurons, the likely
explanations are: 1) WOX1 interacted with and suppressed the
promoter activation regulated by prosurvival CREB, thus
leading to apoptosis. 2) Also, WOX1 potentiated NF-kB
Figure 3. Accumulation of p-CERB in the nuclei of axotomized DRG neurons. (A) By immunohistochemistry, sciatic nerve transection
induced phosphorylation of CREB (p-CREB) in neurons ipsilateral to injury with time, and that nuclear p-CREB is mostly present in the small neurons.
(B) The bar graphs show that p-CREB is expressed at significantly higher levels in the small neurons than in the medium-large neurons (p,0.0001,
n=4, Student’s t test). Approximately 500 cells were counted from 4 tissue sections. Contra, contralateral. Ipsi, ipsilateral.
doi:10.1371/journal.pone.0007820.g003
WWOX/WOX1 in Axotomy
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totic effect.
During the acute phase of injury, JNK1 activation occurred, along
with concurrent upregulation of Wwox mRNA levels, in DRG
neurons within 30 minutes after sciatic nerve transection. The protein
level of WOX1 is then upregulated and accumulated in the nuclei of
DRG neurons within 6 to 24 hr. Relocation of phosphorylated
WOX1 and c-Jun to the nuclei occurred rapidly in injured medium-
large neurons in 6 hr post injury. Also, accumulation of p-WOX1
and p-CREB in the nuclei of small neurons occurred simultaneously.
24 hr later, p-WOX1, p-JNK1 and many transcription factors were
accumulated in the nuclei of both injured and non-injured neurons.
Differential regulation of transcription factors by WOX1 is probably
needed to cope with the acute injury. JNK1 counteracts the function
of WOX1 in apoptosis [13,15]. Conceivably, functional antagonism
between JNK1 and WOX1 determines neuronal survival or death at
this acute stage of injury in vivo.
In the chronic phase, dramatic coactivation of WOX1 with
CREB (.65% neurons) and NF-kB (40–65%) occurred mainly in
small DRG neurons at the second month just prior to neuronal
apoptosis. We have provided supporting evidence that WOX1
differentially regulates the activation of transcription factors, which
may account for the initiation of neuronal apoptosis. The likely
causative events for leading to neuronal death are: 1) WOX1 binds
CREB and c-Jun in vivo, 2) WOX1 inhibits promoter activation by
the neuroprotective CREB, but enhances the activation by
proapoptotic NF-kB, and 3) WOX1 functional augmentation in
apoptosis is observed due to its suppression of CREB transcrip-
tional activation.
More specifically, WOX1 binds CREB via its WW domains,
and the binding occurs most strongly in the nuclei, as determined
by FRET and immunoelectron microscopy. Hypoxic stress further
strengthened the binding. This binding allows WOX1 inhibition
of CREB-regulated promoter activation. Importantly, the binding
Figure 4. Dramatic co-activation of WOX1, CREB and NF-kB in small neurons post axotomy for 2 months. Accumulation of WOX1 and
transcription factors in the nuclei of injured and control DRG neurons is shown in a time-course experiment. Of particular note is that dramatic co-
activation of WOX1 (.65% of cells), CREB (.65%) and NF-kB (40–65%) occurred in small neurons at month 2 post-injury. Criteria for calculating
nuclear localization is shown (top panel). Approximately 150 cells were counted from 4 tissue sections at 2006magnification. n.d.=not done. Contra,
contralateral (non-injured side). Ipsi, ipsilateral (injured side).
doi:10.1371/journal.pone.0007820.g004
WWOX/WOX1 in Axotomy
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WOX1-induced apoptosis.
The N-terminal WW domain area of WOX1 enhanced NF-kB
transcriptional activation in vitro. Although NF-kB is generally
considered as a prosurvival factor, activation of NF-kB may lead to
apoptosis [40,41]. For example, in response to doxorubicin, NF-
kB provides a proapoptotic signal via repression of antiapoptotic
target genes [41]. We have determined that WOX1 physically
binds IkBa, the inhibitor of NF-kB, in culture cells and in organs
(Chang et al., unpublished). This binding may result in
accumulation of NF-kB in the nuclei and increases in promoter
activation (Huang et al., unpublished). Importantly, although there
is no direct binding interaction, together WOX1 and NF-kB
induce apoptosis of neuroblastoma cells in a synergistic manner
(data not shown).
By ectopic expression, Gaudio et al demonstrated the binding of
c-Jun with human WWOX and shown inhibition of c-Jun-
regulated promoter activation by WWOX [42]. In this study, we
demonstrated mouse WOX1 physically interacted with p-c-Jun in
the injured neurons in rat DRGs, and enhanced the promoter
activation governed by c-Jun in vivo. Both human and mouse
WWOX/WOX1 share 96% sequence identity and the N-terminal
WW domain areas of both proteins are identical. Thus, differences
in the results regarding regulation of c-Jun promoter activation are
probably due to alteration of WWOX/WOX1 conformation by
few residues located at the C-terminal SDR domain.
Activation of transcription factors occurs during neuronal
injury; however, their roles in neuronal degeneration and
regeneration are largely unknown. These factors include imme-
diate-early inducible transcription factors c-Jun, c-Fos, ATF/
CREB and others [17,21,43,44]. ATF2 and ATF3, members of
ATF/CREB family of transcription factors, are induced in various
damaged tissues for transcriptional control of stress-response genes
[17,45]. Stress signal-induced ATF3 expression, via JNK and p53
pathways, has been shown in various types of cells [46,47]. JNK
phosphorylates ATF2 to enhance its transcription potential, and
ATF2 acts synergisitically with p53 to carry out DNA repair [48].
CREB undergoes phosphorylation and exerts a prosurvival effect
by regulating the transcription of prosurvival factors, including
bcl-2, in response to oxidative stress [18,26,39,49,50].
Figure 5. WOX1 modulates promoter activation driven by multiple transcription factors. (A) A schematic diagram for the Gal4-based
promoter activation assay using luciferase reporter is shown. (B–D) EGFP-WOX1 was transiently overexpressed in HEK-293 fibroblasts, in the presence
of a specific promoter construct and a luciferase reporter [31,32]. In control cells, EGFP and Gal4-CMV vectors were used, which showed no promoter
activation. Transiently overexpressed WOX1 significantly enhanced the promoter activity regulated by c-Jun and Elk-1 (p,0.0005, n=3, Student’s t
test), but blocked the activation of promoter elements responsive to transcription factors CREB, CRE, and AP-1 (p,0.005, n=3). (E) Neuroblastoma
SK-N-SH cells were transfected with an indicated construct for ECFP-tagged WOX1 or ECFP alone, in the presence or absence of an NF-kB promoter
(using GFP as reporter). The wild type WOX1 significantly increased promoter activation by 4.69 fold (mean6standard deviation, n=10), compared to
ECFP alone (p,0.00001). By domain mapping, the N-terminal first and second WW domains of WOX1 dramatically enhanced the activation of
promoter by 7.90 fold. However, SDR domain had no effect. A schematic structure of WOX1 is shown. (F) In control experiments, no promoter
activation was observed using a negative, a positive, and an NF-kB promoter only in transfecting SK-N-SH cells.
doi:10.1371/journal.pone.0007820.g005
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promoter activation governed by CREB, CRE, and AP-1, but
enhanced the activation by c-Jun, Elk-1 and NF-kB. How these in
vitro observations are interpreted in vivo remains to be established.
AP-1 proteins include the JUN, FOS, ATF and MAF protein
families. These proteins form a variety of homodimers and
heterodimers through their leucine-zipper domains. These dimer
combinations allow recognition of different sequence elements in
the promoters and enhancers of target genes. We determined that
proteins in the AP-1 complexes are differentially regulated by
WOX1. Mechanisms of this regard are required further
elucidation.
Cumulative studies have shown that ectopic WOX1 induces
apoptosis in several types of cancer cells, whereas the underlying
mechanisms are largely unknown [10]. Ectopic WOX1-mediated
upregulation of proapoptotic p53 and downregulation of anti-
apoptoticBcl-2andBcl-xLhasbeenshowninL929fibroblasts.This
event leads to enhancement of the cytotoxic function of tumor
necrosis factor [6]. Overexpressed WOX1 alone induces death of
L929 in a caspase-independent manner [6]. Adenoviral human
WWOX induces apoptosis of prostate DU145 cells in a caspase-
dependent manner, as shown at the end-point of experiments for
more than 48 hr [51]. Similar observations were shown in lung
cancer A549 and H460 cells [52]. A likely scenario is that WWOX/
WOX1 invokes a caspase-independent pathway of apoptosis
initially, followed by activation of caspases during long-term assays.
WOX1 is essential for p53-mediated cell death through binding
and stabilizing phosphorylated p53 [7]. Here, we showed that p53
expression is relatively low in the DRG and spinal cord, and did
not undergo significant changes upon axotomy in animals. In p53-
deficient mice, the induced WOX1 nuclear accumulation occurs
similarly to that in normal controls, indicating that WOX1
activation is independent of p53. Actually, WOX1 can act alone in
the absence of p53 [6,7,13]. So far, we have no direct evidence
showing that p53 and WOX1 physically interact during peripheral
nerve injury. Similarly, Smad4 of the TGF-b pathway was not
expressed in the damaged neurons, but significantly upregulated in
glial cells, suggesting that Smad4 may induce apoptosis of these
cells.
By immunoprecipitation, we showed that WOX1 binds CREB
and c-Jun in non-stimulated SK-N-SH neuroblastoma cells. We
confirmed these observations by immuno-EM, and showed the
complex formation of WOX1 with c-Jun on day 3rd post axotomy
in rats. Also, binding of WOX1 with CREB was shown at day 1
post axotomy, and the complexes were observed in the cytosol,
perinuclear area and nuclei. Moreover, CREB potentiates the
function of WOX1 in causing apoptosis of neuroblastoma cells.
Thus, it is reasonable to postulate that CREB and WOX1
synergistically promote degeneration of axotomized neurons in
vivo.
Finally, WOX1 is the potential target for drug intervention in
mitigating symptoms in patients suffering from devastating
neuronal injury. That is, prevention of WOX1 activation will
prolong cell survival at both chronic and acute phases of neuronal
injury. In our recent study [3], we have determined that a
synthetic 12-amino-acid peptide of WOX1, with phosphorylation
Figure 6. The WW domain area of WOX1 binds CREB most strongly in the nucleus. Rat DRG neurons were cultured overnight and
transfected with WOX1-DsRed and CREB-EGFP. (A) In controls, EGFP did not bind DsRed, as revealed by very low binding energy (FRETc; see color
scale). Scale bar=20 mm. (B,C) Both the full-length WOX1 and the WW domain area bound CREB most strongly in the nuclei rather than in the
cytoplasm. N=nucleus, C=cytoplasm. (D) Exposure of neurons to DFO (500 mM) for 2 hours to induce hypoxic conditions resulted in increased
binding of WOX1 with CREB in both cytoplasm and nuclei. (E) The bar graph shows the increased binding when both proteins are in the nuclei, and
DFO significantly increased the binding (average 6 standard deviations, n=7; Student’s t tests for all WOX1/CREB interactions versus GFP/DsRed).
doi:10.1371/journal.pone.0007820.g006
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MPP
+ (1-methyl-4-phenylpyridinium). Whether this phospho-
peptide blocks axotomy-induced neuronal death remains to be
established. In addition, there is a likely scenario that WOX1 may
undergo degradation during stress response, thereby generating
short peptides, which are capable of counteracting apoptosis.
Methods
Animals
All experiments involved animals were approved by the
Institutional Animal Care and Use Committee (IACUC) of the
National Cheng Kung University Medical College. All procedures
were performed in accordance with the guidelines of the National
Institutes of Health, USA. Adult male Sprague-Dawley rats (250–
300 g) were used. The animals were anesthetized with a mixture of
ketamine (80 mg/kg) and xylazine (8 mg/kg). Under sterile
surgical conditions, skin was incised from the level of the sciatic
notch to the knee, and the sciatic nerve was transected unilaterally
at the mid thigh level. Approximately 2 mm of the distal stump
was removed. Muscle was repositioned without sutures and skin
was closed with wound clips. After surgery, rats were recovered
under incandescent lamp and housed for half and several hours to
weeks and months, as indicated. In sham controls the nerve was
exposed but without transection.
p53 Knockout Mice
WOX1 physically interacts with p53 in cultured cells [6–8,13].
We examined whether p53 deficiency affects WOX1 functions. p53
wild-type C57BL/six (p53
+/+) and knockout p53N4-M (p53
+/2 and
p53
2/2) mice were used [16]. These mice were undergone sciatic
nerve transection and then sacrificed 1–3 days later, followed
by preparing tissue sections (described below) and determining
WOX1 accumulation in the nuclei of neurons in DRG and spinal
cord.
Tissue Preparations and Sections
Preparation of tissue sections was carried out as described
[2,16]. Sacrificed animals were perfused via aorta with phosphate-
buffered saline, followed by fixing with freshly prepared 4%
paraformaldehyde. The L4 and L5 DRG and spinal cord were
harvested and fixed overnight at 4uC. Serial tissue sections were
5 mm in thickness. Every 4-sections was a group: the first ones
stained with cresyl violet for neuronal counting, and the others for
immunohistochemistry using specific antibody against WOX1,
p-WOX1, c-Jun, or indicated antibodies.
Antibodies, Immunohistochemistry, and
Immunofluorescence Microscopy
Specific antibodies against indicated proteins were: 1) a region
between the first and second WW domains of WOX1 [6], the first
WW domain of WOX1 [16], a phospho-Tyr33 WOX1 peptide (p-
WOX1) [13], and WWOX peptides (N-19 and P-20) (Santa Cruz
Biotechnology); 2) JNK1, phospho-JNK (p-JNK), c-Jun, phospho-
c-Jun, c-Fos, ATF2 and ATF3 (Santa Cruz Biotechnology), CREB
and phospho-CREB (p-CREB) (Cell Signaling); 3) caspase-1, 3, 8,
9, and caspase-activated DNase (CAD) (Santa Cruz Biotechnol-
Figure 7. Axotomy-induced complex formation of p-WOX1 with p-CREB in vivo determined by immunoelectron microscopy
(Immuno-EM). Complex formation of p-WOX1 and p-CREB in the injured DRG neurons was greater in the ipsilateral side (b,d) than in the
contralateral side (a,c). p-CREB, 20-nm anti-rabbit immunogold IgG particles (large); p-WOX1, 10-nm immunogold anti-goat IgG particles (small). Note
the presence of p-WOX1/p-CREB complexes in the nucleus, nuclear envelope and cytosol in the ipsilateral side. Selected areas from a,b were
magnified and shown in c,d.
doi:10.1371/journal.pone.0007820.g007
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and spinal cord sections was performed using the avidin-biotin
peroxidase technique (Vector) and glucose oxidase-nickel-diami-
nobenzidine (DAB) enhancement [2,16]. The positive signal is
‘‘blue’’ in color. Alternatively, an immunohistochemistry kit was
purchased from DAKO Biotechnology for ‘‘brown’’ color
development. For dual immunofluorescence, tissue sections were
stained with anti-WOX1 and indicated antibodies. Texas Red-
tagged anti-rabbit IgG and FITC-tagged anti-mouse (or goat) IgG
were for secondary staining. Nuclei were stained with 4,6-
diamidino-2-phenylindole DAPI (Sigma). In negative controls,
secondary antibodies were used for cell staining only.
Western Blotting and Co-Immunoprecipitation (Co-IP)
DRGs and dorsal/ventral horns of the spinal cords were
isolated from control and experimental animals (without perfusion
fixation), and extracted with a lysis buffer containing 5 mM Tris
(pH 8.5), 2% SDS, 10% glycerol, and a cocktail of protease
inhibitors (Roche). SDS-PAGE and Western blotting were
performed using indicated antibodies. For co-immunoprecipita-
tion [6–8,13], human SK-N-SH neuroblastoma cells were grown
up to near 100% confluence and cultured in fresh serum/medium
overnight prior to experiments. Cells were exposed to ischemic
conditions (1% oxygen and low glucose) for 2 hours, harvested,
extracted, and then quantified (Pierce Micro-BCA kit). The cell
lysates were precleared with protein A agarose beads, followed by
processing immunoprecipitation using anti-WOX1 IgG and
protein A agarose beads. Presence of WOX1 and other indicated
proteins in the precipitates was determined by Western blotting
using specific antibodies. Non-immune serum or IgG was used in
negative controls (data not shown).
Immunoelectron Microscopy
Isolated rat DRGs were fixed for 1 hour using a freshly
prepared 4% solution of paraformaldehyde in phosphate-buffered
buffer. The tissues were then immersed in 1% osmium tetroxide,
dehydrated in a graded series of ethanol, and finally embedded in
resin (EMS, SPUR’s Kit). Ultrathin sections (70–80 nm) were
prepared with an ultramicrotome (Reichert-Jung) and hybridized
with an aliquot of IgG antibody against WOX1, p-WOX1 or
indicated proteins, followed by probing with a secondary anti-
rabbit IgG 20 nm A-gold probe or anti-mouse (or goat) 10 nm
gold particles, as described [2,16,30]. The sections were stained
with saturated aqueous uranyl acetate and lead citrate at room
temperature. Specimens were then observed under a transmission
electron microscopy (JEOL JEM-1200EX, Japan) at 100 kV.
Preparation of Wwox Probes for In Situ Hybridization and
mRNA Quantification
Digoxigenin-labeled sense and antisense cRNA probes used for
in situ hybridization were generated from human WWOX gene in
exons 8 through 9 (nucleotides 976–1466) with 83% sequence
Figure 8. CREB enhances the apoptotic function of WOX1. (A) SK-N-SH neuroblastoma cells were transfected with a non-apoptotic dose of
WOX1, in the presence of various amounts of CREB by electroporation. These cells were cultured for 48 hr. Cell cycle analysis by flow cytometry showed
that CREB enhanced the apoptotic function of WOX1 (see the increased cell population at the SubG1 but reduced population at G0/G1 phases). CREB
alone had no effect on apoptosis. (B) Under similar conditions, when cells were transfected with CREB and a dominant negative WOX1 (dn-WOX1), little
or no apoptosis occurred. dn-WOX1 blocks WOX1 phosphorylation at Tyr33 [13]. As a positive control of apoptosis, staurosporine (stauro) was used.
doi:10.1371/journal.pone.0007820.g008
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tissue sections was performed as previously described [14]. For
quantification, randomly selected 30–50 cells were from each
section (3–5 sections used), and the intensity of each individual cell
was quantified by a software program ImagePro from Media
Cybernetics. Statistical analysis was performed by one-way
ANOVA (Excel, Microsoft).
TUNEL Assay
TUNEL (TdT-mediated dUTP-dioxigenin nick-end labeling)
assay kit (Oncogene), containing horseradish peroxidase-labeled
anti-biotin and hydrogen-peroxide-DAB solution, was used to
detect internucelosomal DNA fragmentation during neuronal
apoptosis by specifically labeling the 39-hydroxyl termini of
breakages of the DNA strands in tissue sections (Chuang and
Chen, 2002). In negative controls, sections were subjected to sham
reaction without biotinylated 16-dUTP.
Quantification for Protein Nuclear Accumulation and
Statistical Analysis
Neuron counting was carried out in 20 serial sections (stained
with cresyl violet). Ganglia cells and motoneurons of the
ventrolateral group (lamina IX) were examined based on their
relatively large-sized nucleoli under microscopy [54 ]. The non-
operated side of DRG or spinal cord was considered as controls.
Nuclear accumulation of indicated proteins (e.g. p-WOX1 and p-
CREB) was counted in both ipsilateral and contralateral sides as:
1) high, .65%, 2) moderate, 40–65%, 3) low, 20–40%, 4) very
low, ,20%, and 5) none, 0%. Neurons were counted from 4
randomly selected microscopic fields at 2006 magnification. P
value less than 0.05 is regarded as statistically significant (ANOVA
and Student’s t-test).
Quantitative Polymerase Chain Reaction (qPCR)
DRGs were isolated following axotomy for 0, 30, 60 and
120 min. Total RNA was isolated using TRIzol Reagent
(Invitrogen), and reverse-transcribed using random hexamers
and oligo-dT primers (Chang et al., 2001). qPCR was performed
in a Cepheid machine using SYBR Green (TaKaRa) and the
following primers: WOX1 primer forward, AATCGAATT-
CAATGGCAGCTCTGCGCTAT; WOX1 primer reverse,
TTCAGAATTCT TAGTCCACGGTAAATGCCAA; GAPDH
primer forward, ACCACAGTCCATGCCATC; GAPDH primer
reverse, CAGGTTTCTCCAGGCGGC. All amplifications were
performed in triplicates using 1 ml of the first strain cDNA per
reaction. Cycle of threshold (Ct) was determined from the
triplicate experiments using the GAPDH gene transcription as
reference for normalization.
Cell Cycle Analysis
SK-N-SH cells were transfected with expression constructs of
WOX1 and/or CREB (or vector only) by electroporation and
then cultured for 24 hr. To determine the extent of cell death, cell
cycle analyses were carried out to measure the cellular DNA
contents using a fluorescence-activated cell sorting (FACS)/flow
cytometry machine (BD), as previously described [13].
Fo ¨rster (Fluorescence) Resonance Energy Transfer (FRET)
Time-lapse FRET analysis was performed as described [30].
The full-length and the N-terminal WW domains of murine
WOX1 were constructed in-frame with DsRed (destabilized red
fluorescence protein, pDsRed2-C1 vector, Clontech) and rat
CREB in frame with EGFP (p-EGFP-C1 vector, Clontech),
respectively. Rat DRG neurons were cultured on cover slips
overnight and transfected with both constructs by liposome-based
Genefector (VennNova) and cultured 24–48 hr. FRET analysis
was performed using an inverted fluorescence microscope (Nikon
Eclipse TE-2000U). Cells were stimulated with an excitation
wavelength 455 nm. FRET signals were detected at an emission
wavelength 600 nm. EGFP and DsRed2 were used as donor and
acceptor fluorescent molecules, respectively. The FRET images
were corrected for background fluorescence from an area free of
cells and spectral bleed-through. The spectrally corrected FRET
concentration (FRETc) was calculated by Youvan’s equation
(using a software program Image-Pro 6.1, Media Cybernetics).
The equation normalizes the FRET signals to the expression levels
of the fluorescent proteins:
FRETc=(fret-bk[fret])-cf[don]*(don-bk[don])-cf[acc]*(acc-bk[acc]),
where fret=fret image, bk=background, cf=correction factor,
don=donor image, and acc=acceptor image.
In a parallel approach, FRET analysis was also performed by
using ECFP-WOX1 proteins and EYFP-CREB, as described [30].
Effect of WOX1 on Promoter Activities Driven by
Transcription Factors
The effect of WOX1 on responsive promoters driven by
transcription factors was determined using the following reporter
constructs (Stratagene), as described [31,32]: (a) Luciferase
reporter gene linked to tandem repeats (4X) of CRE and AP-1,
respectively; (b) A Gal4 reporter system specific for transactiva-
tional activity of CREB, c-Jun and c-Elk-1, respectively. This Gal4
system consists of a luciferase reporter gene driven by four copies
of the Gal4 regulatory sequence (pGal4-TK-Luc) along with the
expression vectors for a chimeric protein, Gal4-CREB, which
consists of the DNA binding domain of Gal4 and the transactiva-
tion domain of CREB, c-Jun, or c-Elk-1. HEK 293 cells were
cultured to around 70% confluence in 6635 mm plates. Transient
transfection with the CREB-responsive reporter (or other above-
mentioned constructs) and the expression EGFP-WOX1 construct
was carried out using LipofectAMINE Plus reagent (Invitrogen). A
plasmid containing b-galactosidase gene driven by SV40 promoter
was included in the transfection mixture to normalize the
transfection efficiency. Luciferase was assayed using the enhanced
luciferase assay kit (Pharmingen/Invitrogen) on a Monolight 2010
luminometer. The colorimetric assay of b-galactosidase was
carried out as described [31,32].
Promoter Activation Assay Using GFP as Reporter
An assay kit for the promoter function driven by NF-kB was
from SABiosciences. Neuroblastoma SK-N-SH cells were trans-
fected with a promoter construct using GFP as a reporter by
electroporation (200 volt and 50 msec; using a BTX ECM830
electroporator from Genetronics) or using liposome-based Fu-
GENE 6 (Roche) or Genefector (VennNova). Also, expression
constructs for WOX1, the WW domains, and the SDR domain (all
tagged with ECFP) were included in the mixtures for electropo-
ration. The cells were cultured for 24 hr. Promoter activation was
examined under fluorescence microscopy. Both positive and
negative controls from the assay kit were also tested in each
experiment. Little or no leaking of ECFP signal to the GFP
channel was observed (see Fig. 4).
Supporting Information
Figure S1 Morphological changes of DRG neurons post
peripheral nerve injury in rats. Chromatolysis (a redistribution of
Nissl substance) in the transected DRG neurons was not detected
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Presence of eccentric nuclei (arrows in d,f) and large vacuoles in
the cytosol (arrowheads, d) was observed in injured neurons 3–7
days post injury, but not observed in the contralateral side (c).
However, nuclear sizes, staining density of the chromatin and
locations of the nucleoli were apparently normal 8 weeks (60 days)
after surgery (e,f). No TUNEL-positive neurons were observed in
the contralateral intact side (g), whereas few condensed TUNEL-
positive cells (less than 5% of total neurons) are present in the
ipsilateral DRG 60 days later (h, arrows). See the enlarged insert
for TUNEL-positive cells (i).
Found at: doi:10.1371/journal.pone.0007820.s001 (1.51 MB TIF)
Figure S2 Accumulation of WOX1 in the nuclei of injured
DRG neurons. By immunohistochemistry, accumulation of
WOX1 in the nuclei was observed in the ipsilateral DRG neurons
6 hr after axotomy (arrows in d), as compared to the early stage (b)
or the contralateral side (a, c) and normal control (insert).
Increased nuclear translocation of WOX1 continued to occur 3
days after axotomy (f). Notably, upregulation of WOX1
expression, along with nuclear translocation, occurred in numer-
ous DRG neurons contralaterally to the surgical site several days
(e) to weeks (g) later. Interestingly, WOX1 immunoreactivity is
mainly present in small-sized neurons (arrow), and is also positive
in few medium-to-large neurons (arrowhead in g). Presence of
cytosolic and nuclear WOX1 is shown in ipsilateral DRG neurons
after injury for 2 months (h). Insert: a negative control.
Found at: doi:10.1371/journal.pone.0007820.s002 (0.56 MB TIF)
Figure S3 Significant accumulation of p-WOX1 in the nuclei of
small neurons in both injured and non-injured DRGs at month 2.
Distribution of activated WOX1 (p-WOX1) in the nuclei is shown
in small and medium-large neurons post axotomy at indicated
times. No differences were shown in the extent of nuclear
localization of p-WOX1 between medium-large neurons and
small neurons during the first week post axotomy. At month 2,
nuclear accumulation of p-WOX1 was significantly greater in the
small neurons than in the medium-large neurons in both
contralateral and ipsilateral sides (p,0.01; n=3; approximately
50–150 neurons counted per DRG section). Sham, sham
operation; 6 h, 6 hours; 1 d, 1 day; 7 d, 7 days; 2 m, 2 months.
Found at: doi:10.1371/journal.pone.0007820.s003 (1.52 MB TIF)
Figure S4 Expression of Wwox gene and protein in the spinal
cord. (A,B) In situ hybridization analyses revealed that there was
little or no difference in the Wwox mRNA expression in the dorsal
horn either in the contralateral (control) or ipsilateral (operated)
side post surgery for 3 days. Also, there were no apparent
differences in the numbers of Wwox mRNA-expressing neurons in
both sides. (C) The protein levels of WOX1 expression are similar
in both the contralateral and ipsilateral sides. Bar=20 mm (for
B,C). Accumulation of WOX1 is shown in the nuclei.
Found at: doi:10.1371/journal.pone.0007820.s004 (1.85 MB TIF)
Figure S5 Accumulation of p-WOX1 in the nuclei of spinal
neurons. In the L4 spinal cord, accumulation of p-WOX1 in the
nuclei is shown 3 days post injury (a). See the enlarged ventral
horns, contralateral (c) and ipsilateral (d), for p-WOX1 nuclear
accumulation. Normal motoneurons did not express p-WOX1 (b).
Scale bar=20 mm (except a).
Found at: doi:10.1371/journal.pone.0007820.s005 (2.18 MB TIF)
Figure S6 Axotomy-induced protein accumulation of WOX1 in
the nuclei. Accumulation of WOX1 protein in the nuclei occurred
6 hr post axotomy in rats, as determined using cytoplasmic and
nuclear preparations of DRGs in Western blotting.
Found at: doi:10.1371/journal.pone.0007820.s006 (0.21 MB TIF)
Figure S7 WOX1 protein expression in the spinal cord. Sciatic
nerve transection did not produce differences in WOX1 protein
expression in both the dorsal and ventral horns of spinal cord post
injury for 1 day to 2 weeks. Contra, contralateral (control side).
Ipsi, ipsilateral (injured side).
Found at: doi:10.1371/journal.pone.0007820.s007 (2.12 MB TIF)
Figure S8 Smad4 is barely present in axotomized DRG
neurons. Smad4 was not expressed in the neurons in both
ipsilateral and contralateral sides with time of insult. Smad4 was
mainly present in the glial cells, and the levels of expression were
greatly increased at month 2.
Found at: doi:10.1371/journal.pone.0007820.s008 (2.48 MB TIF)
Figure S9 Colocalization of p-WOX1 with p-c-Jun by immuno-
EM. Immuo-EM shows colocalization of p-WOX1 (10-nm
immunogold anti-goat IgG particles) with p-c-Jun (20-nm anti-
rabbit immunogold IgG particles) in the nuclei (N) of large
neurons (a) and small neurons (b) 6 hours post axotomy. No
apparent binding is shown. Note that the total numbers of particles
are greater in medium-to-large neurons (a) than in small neurons
(b). (c) At a higher magnification, no apparent binding between p-
WOX1 and p-c-Jun is shown (magnification from b). Three days
later, there was an increased binding of p-WOX1 with c-Jun in the
nuclei of small DRG neurons (d). The protein complexes were co-
expressed in the cytosol, within and outside transport vesicles (e, f).
p-c-Jun, large particles; p-WOX1, small particles.
Found at: doi:10.1371/journal.pone.0007820.s009 (1.65 MB TIF)
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